Overview
Rotavirus gastroenteritis primarily affects infants and young children under five years old, causing significant morbidity and mortality, particularly in developing countries. Despite vaccination efforts, it remains a global health concern, leading to approximately 200,000 child deaths annually worldwide 1.Diagnosis
Management
Special Populations
Key Recommendations
References
1 Sharma AD, Magdaleno JSL, Singh H, Orduz AFC, Cavallo L, Chawla M. Immunoinformatics-driven design of a multi-epitope vaccine targeting neonatal rotavirus with focus on outer capsid proteins VP4 and VP7 and non structural proteins NSP2 and NSP5. Scientific reports 2025. link 2 Edwards N, Abasszade JH, Nan K, Abrahams T, La PBD, Tinson AJ. Severe Adult Rotavirus Gastroenteritis: A Rare Case with Multi-Organ Failure and Critical Management. The American journal of case reports 2023. link 3 Hibbs BF, Miller ER, Shimabukuro T. Notes from the field: rotavirus vaccine administration errors--United States, 2006-2013. MMWR. Morbidity and mortality weekly report 2014. link 4 Madden V. An end to rotavirus misery. Nursing standard (Royal College of Nursing (Great Britain) : 1987) 2006. link 5 Limbos MA, Lieberman JM. Disseminated intravascular coagulation associated with rotavirus gastroenteritis: report of two cases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996. link